The 18th Annual Pain Therapeutics Summit serves as a catalyst for collaboration between academia, industry, and regulatory bodies, fostering a multidisciplinary exchange of ideas, expertise, and resources. Gain invaluable insights from renowned experts, network with key stakeholders, and stay at the forefront of emerging trends and breakthroughs in pain drug development.

Tickets: https://go.evvnt.com/2458285-1?pid=91 

Prices:

Industry (price tba): USD 0.00,

Academic/Government (price tba): USD 0.00,

Post-Doctoral Scholar (price tba): USD 0.00,

Student (price tba): USD 0.00

Speakers: William Schmidt, Ph.D. President, NorthStar Consulting, Mary Ann Pelleymounter, Ph.D. Program Director, NINDS, Division of Translational Research, National Institutes of Health , Neil Singla, MD Chief Scientific Officer, Lotus Clinical Research , Ram Arudchandran, Ph.D. Program Director, National Institute of Neurological Disorders and Stroke, Robert Dworkin, Ph.D., Professor of Anesthesiology and Perioperative Medicine, Professor of Neurology, University of Rochester School of Medicine and Dentistry, John Markman, MD, Vice President Global Pain, Eli Lilly, Christin Veasley, Co-Founder and Director, Chronic Pain Research Alliance, Katie Holzer, Ph.D., LCSW Assistant Professor of Anesthesiology, Washington University School of Medicine, Lynn Webster, MD, Executive VP Scientific Affairs, Dr. Vince Clinical Research, Eric Nisenbaum, Ph.D., Sr. VP, President, Head Boston Innovation Hub, Grunenthal Group